Investment in Innovation to Improve Patient Outcomes

Ever wondered why innovation is so important for creating and sustaining markets that lead to progress in healthcare? Or how to integrate innovation into your business strategy while still meeting commercial priorities?  Galen/Atlantica specializes in creating models for product development, value recognition, and healthcare access in order to help companies keep pace with evolving scientific and business realities.  Come hear case studies spanning drug development, evaluation, and use in the neuroscience to see how we can improve patient outcomes.

Matt Diver’s career spans service as a Peace Corps Volunteer in Africa, investment banker in the technology sector, and a manager at Boston Consulting Group. He holds a business degree from UC Berkeley and a master’s in public policy from Harvard’s Kennedy School. He co-founded Galen/Atlantica in 2015 after serving as a partner at Tapestry Networks, where he led collaborations of senior executives of the pharmaceutical industry, government agencies, civil society, and key opinion leaders to advance responsive and sustainable healthcare innovation.